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Abstract
Background: Trichorhinophalangeal syndrome (TRPS) is a rare autosomal dominant disorder caused by defects
involving the TRPS1 gene. It exhibits distinctive craniofacial, ectodermal and skeletal abnormalities, such as sparse
hair, bulbous nasal tip and short deformed fingers, with extremely variable expressivity.
Case presentation: We report the case of a 17 months old girl, who presented growth retardation and dysmorphic
features. Postnatal growth was always below − 2 Standard Deviation for both weight and length and physical examination
revealed relative macrocephaly, sparse hair, bulbous nasal tip, thin upper lip, protruding ears, prominent forehead, small jaw,
and short hands and feet. Patient’s mother shared the same facial features, and presented sparse hair and small
hands. The maternal grandfather and two uncles presented short stature, bulbous nasal tip, thin hair, and premature
alopecia. Molecular analysis of TRPS1 gene showed a heterozygous c.2086C > T;(p.Arg696Ter) mutation both in
the patient and her mother, confirming the diagnosis of TRPS, type I.
Conclusions: Clinical phenotype of TRPS can be subtle and the syndrome often remains undiagnosed. A comprehensive
clinical examination and an exhaustive family history are crucial to reach the correct diagnosis, which is essential to perform
adequate follow-up and timely therapeutic procedures.
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Introduction
Trichorhinophalangeal syndrome (TRPS) is a rare dis-
order characterized by distinctive craniofacial and skeletal
abnormalities, first described in 1966 by Giedion, who
named the syndrome on the basis of the three main fea-
tures: sparse hair, bulbous nasal tip and short deformed
fingers [1].
TRPS is caused by a pathogenic variant of the TRPS1
gene, inherited in an autosomal dominant manner, with
high penetrance and variable expressivity. The disease
could also be a result of a de novo mutation [2].
Three subtypes of TRPS are described: TRPS I, TRPS
II and TRPS III, differing in clinical characteristics and
pattern of mutation in the TRPS1 gene. All three sub-
types of TRPS presented distinctive craniofacial features,
ectodermal and skeletal anomalies. Craniofacial features
include bulbous tip of the nose, long flat philtrum, thin
upper lip with vermilion border and protruding ears.
Ectodermal anomalies consist of slowly growing and
sparse scalp hair, with receded medio-occipital hairline,
medially thick and laterally thin eyebrows, dystrophic
nails and dental anomalies, such as supernumerary teeth.
Skeletal anomalies include short phalanges and short
metacarpals (mild to severe brachydactyly), ulnar or
radial deviation of the fingers, cone-shaped epiphyses,
hip malformations and short stature [3]. TRPS II is char-
acterized by multiple exostoses and an increased risk of
mild-to-moderate intellectual disability. TRPS III is
considered an extreme of the clinical spectrum of TRPS
I, with more severe brachydactyly due to short metacar-
pals, and severe short stature.
Clinical presentation could vary widely, from simple
change in the phalanges to low bone mineral density
with high risk of fragility fractures. Furthermore, there
are reports of cardiac and neurologic abnormalities [5].
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The exact prevalence of TRPS is not known. Around
100 cases of TRPS I and TRPS III and 100 cases of TRPS
II were published until June 2017. However, given the
widely variable manifestations, many cases of TRPS
probably remain undiagnosed [4].
Case report
We describe the case of a 13 months’ girl, brought to the
gastroenterology department of a third level pediatric
hospital because of failure to thrive.
The patient was the only child born to unrelated parents.
During pregnancy, first-trimester combined test showed ab-
normal values of pregnancy-associated plasma protein
(PAPP-A) and free beta human chorionic gonadotropin
(β-hCG), while ultrasound test for fetal nuchal translucency
resulted normal. Chorionic villus sampling and cell-free
fetal DNA analyses were performed at 12 weeks’ gestation
(WG) and showed no evidence of chromosomal disorders.
During the sixth month of gestation, prenatal ultrasound
revealed intrauterine growth retardation, hence the mother
was treated with low-molecular-weight heparin. At 38 WG
and 6 days labor was induced, due to the onset of pre-
eclampsia. At birth, the child was small for gestational age.
Birth-weight was 2452 g (− 1.85 Standard Deviation, SD),
length 46 cm (− 1.69 SD) and occipito-frontal head circum-
ference (OFC) 34 cm (− 1.22 SD). Apgar score was 8I to 9V.
The child presented a talipes valgus of both feet, hence was
treated with taping for three months. Neuromotor develop-
ment was normal, nevertheless the child presented speech
delay. Postnatal growth was regular, but always below − 2
SD for both weigh and length (Fig. 1 a, b).
Because of the poor growth the patient underwent several
medical assessments. An endocrinological evaluation was
performed at the age of 8months. Laboratory tests, includ-
ing hemochrome, thyroid function, cortisol, Insulin-like
Growth Factor I (IGF1) and 25-OH Vitamin D3 dosage,
resulted normal; a radiograph of the left hand revealed
delayed bone maturation. Furthermore, CGH-array analysis
was performed; the test excluded the presence of DNA
microdeletion/microduplication.
The patient has come to the gastroenterology department
of our hospital at the age of 13months, because of growth
retardation and behavioral feeding disorders. The parents
reported limited appetite and selective intake of food.
Weight was 6.930 kg (− 2.38 SD), length was 68.4 cm
(− 2.64 SD), OFC was 45.8 cm (+ 0.34 SD). Physical
examination revealed peculiar characteristics: sparse hair,
bulbous nasal tip, thin upper lip, protruding ears, promin-
ent forehead, small jaw, and short hands and feet
(Fig. 2 a, b, c). Advise was given to the family regarding
correct feeding techniques. Furthermore, the patient was
evaluated by the genetics unit of our hospital. Considering
the poor growth, the relative macrocephaly and facial fea-
tures, Silver-Russel syndrome was initially suspected, but
deletion/duplication analysis of 11p15 and methylation
analysis of DMR1 (H19) and DMR2 (KCNQ1OT1) re-
gions showed no anomalies.
On the occasion of a check-up, at the age of 17
months, we noticed that patient’s mother shared the
same facial features of the baby, and presented sparse
hair and small hands. She was 158 cm tall. Extending the
family history, we found out that the maternal grand-
father and the two uncles presented short stature, had
the same bulbous nasal tip and thin hair, furthermore
they developed alopecia before the age of 20. This informa-
tion led us to suspect trichorhinophalangeal syndrome,
inherited from the maternal lineage, hence we decided to
reevaluate the radiograph of the left hand previously made,
which revealed a cone-shape appearance of the last phalan-
ges (Fig. 3). Furthermore, we perform a radiograph of the
hands of patient’s mother, which showed cone-shaped
epiphyses of middle phalanges of 2nd, 3rd and 4th fingers
bilaterally, clinodactyly of the 2nd finger bilaterally, brachy-
metacarpalia of 5th metacarpal bilaterally, with dysmorphic
aspect of distal epiphyses (Fig. 4 a, b). All of these radio-
graphic features were consistent with the hypothesis of
trichorhinophalangeal syndrome.
Molecular study
DNA was extracted from blood samples of both patient
and patient’s mother. Direct sequencing of PCR products
was performed, covering all protein-coding exons of TRPS1
gene and the consecutive intronic regions. Molecular ana-
lysis of TRPS1 gene showed a heterozygous c.2086C >
T;(p.Arg696Ter) mutation in the patient and her mother,
allowing us to confirm the diagnosis of TRPS I.
Discussion
This report reflects the complexity of identifying a patient
with TRPS. This disease is rare and usually not well-known
by doctors; it has extremely variable expression, with clin-
ical phenotypes that might be fairly mild. Therefore, TRPS
often remains undiagnosed. This entails the risk that pa-
tients undergo numerous unnecessary investigations before
reaching the correct diagnosis, which is often made when a
more severely affected family member presents with the
classic phenotype.
In the described case, at least 4 additional family
members had never received a diagnosis. Our patient
had undergone numerous medical assessments and la-
boratory tests, but only a careful medical history and ac-
curate examination allowed the diagnosis, along with the
knowledge of the syndrome.
Our patient was diagnosed at 17 months old, earlier
than most of the cases described in literature. Although
there is currently no curative treatment for TRPS, a cor-
rect diagnosis is essential to perform all the supportive
care that the patient would need. Particularly, timely
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orthopedic procedures can correct functional disability
and physiotherapy can prevent secondary joint degener-
ation and chronic arthralgias. Furthermore, an early
diagnosis allows a strict control of the growth pattern
and an investigation of GH production. In case of poor
growth and GH deficiency, a replacement therapy can
be offered. Mutation analysis extended to the other
family members allows identification of carriers and sub-
sequent genetic counseling.
The molecular study of our patient revealed a pathogenic
mutation on TRPS1 gene. This mutation, c.2086C >T, was
previously described by Dias et al., in a girl with a sporadic
case of TRPS I. In that case, two mutations were found in
the TRPS1 gene, both in heterozygosity, c.1198C >T
(p.Gln400X) and c.2086C >T (p.Arg696X). The patient
presented a pear-shaped nose, a long philtrum, thin lips
and a broad forehead. At four years old, her weight was in
5th, height in 10th, and head circumference in 75th percen-
tiles. The same patient was described by Marques et al.: at
ten years old she presented short stature for her age (− 2.03
SD) with a reduced growth velocity (− 4.07 SD) and a bone
age of 4.5 years. GH stimulation test was performed, show-
ing GH deficiency. Therefore GH replacement therapy was
undertaken, obtaining a satisfying catch-up growth [6, 7].
The case described by Dias et al. and Marques et al.
presented two mutations on TRPS1 gene. Both of them
had not been previously described, hence, we cannot know





Fig. 1 Patient’s growth charts (WHO growth charts for girls ages 0 to 5 years of age). a Length-for-age chart. b Weight-for-age chart
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the patient. Furthermore, the authors could not differenti-
ate whether the two mutations were coexisting in the same
allele or in different alleles. Since the patient manifested the
typical phenotype of heterozygous TRPS I patients, the au-
thors presumed that the two mutations coexisted in the
same allele, behaving as a single mutation. In that case, it is
possible that one of the two mutations was not pathogenic.
Clinical features of the patient described by Dias et al.
and Marques et al appeared comparable with our pa-
tient, therefore we can speculate that the mutation
c.2086C > T (p.Arg696X) could be responsible of the
phenotype. Additional studies could be helpful to clarify
the pathogenic role of these two gene mutations.
Considering the similarities within the described cases,
if growth pattern of our patient will remain below the
normal range, it would be appropriate to perform a GH
stimulation test and a replacement therapy in case of
GH deficiency. Given the good response to the replace-
ment therapy described by Marques et al., we are
confident to obtain a similar outcome.
Trichorhinophalangeal syndrome
Genetics
TRPS1 gene is located on chromosomal band 8q24.1, it
encodes a transcription factor for a zinc-fingerprotein
and represents a candidate gene for bone homeostasis
regulation, as it seems to be involved in regulation of
bone perichondrium mineralization and proliferation
and apoptosis of chondrocytes [6, 9].
TRPS I is caused by heterozygous pathogenic variant
of the TRPS1 gene, which leads to haploinsufficiency of
TRPS1. To date, more than 130 pathogenic variants in
TRPS1 have been reported [10, 15]; 76 mutations are
listed in the public HGMD database (Human Gene
Mutation Database; www.hgmd.org), mostly missense
and nonsense mutations, or small deletions and inser-
tions within the coding part of TRPS1 gene [11].
TRPS II, also known as Langer–Giedion syndrome, is
considered a contiguous gene syndrome, caused by a
larger deletion gene in the long arm of chromosome 8
(8q24.11–13) involving TRPS1 and EXT1 genes. The
Fig. 2 Typical phenotipic features. a Fine and sparse hair. b Bulbous nose, long philtrum, thin upper lip. c Short foot withbrachydactyly of the
2nd finger (c)
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band 8q24.13 contains the EXT1 gene, which encodes a
Golgi localized type 2 transmembrane protein with gly-
cosyltransferase activity. EXT1 seems to have a regula-
tory effect on longitudinal bone growth and is involved
in the development of exostoses. Mental retardation ap-
peared to be correlated with the size of the interstitial
8q deletion [12].
TRPS III represents a variant of TRPS I, several mis-
sense mutations of the same gene have been described
in patients with TRPS III phenotype [10].
Diagnosis
History and physical examination can suggest the diagno-
sis. Every time a patient shows typical craniofacial, ecto-
dermal and skeletal features, TRPS syndrome should be
considered.
Imaging studies, especially of the hands, could be
useful. Radiographic features include: cone-shaped
epiphyses of the middle phalanges of the hands and
feet, present in almost all individuals with TRPS and
detectable typically after 2 years of age, when epiphyses
are just forming; short metacarpals and short phalanges;
clinodactyly. Radiographic studies of pelvis and hip resulted
often unspecific, showing hip anomalies such as coxa vara,
coxa plana, and coxa magna, Perthes disease-like femoral
head changes. Multiple exostoses of long tubular bones are
typical of TRPS II [13, 14].
TRPS I definite diagnosis can be established with the
identification of a heterozygous pathogenic variant in
TRPS1 gene. Sequence analysis of TRPS1 can be under-
taken first. If no pathogenic variant is detected, either
chromosome microarray analysis (CMA) or gene-targeted
deletion/duplication analysis is indicated. Karyotype can
be considered to detect an apparently balanced transloca-
tion or inversion involving 8q24 [8].
If patient present suggestive findings of TRPS II, a CMA
can be performed to identify a contiguous 8q24.11–13 de-
letion that spans the TRPS1-EXT1 interval.
In patient with TRPS phenotype, severe brachydactyly
and severe short stature, TRPS III may be suspected.
Fig. 3 Radiograph of patient’s left hand. Delayed bone maturation,
cone-shape appearance of distal phalanges. (We could not perform a
morphologic radiographic study due to the lack of images for third
and fourth distal phalanges)
Fig. 4 Radiograph of the mother’s left hand with morphologic study.
a Cone-shaped epiphyses of middle phalanges, clinodactyly of 2nd
finger, and brachymetacarpalia of 5th metacarpal. b Morphologic
radiographic study: several bone segments are below − 2. Standard
Deviation (SD): particularly, the fifth metacarpal bone is below − 5 SD
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The identification of a specific missense mutation can
support the diagnosis.
Molecular genetic testing is not always required to
make the diagnosis, as the phenotype is often noticeable
and distinct. However, molecular confirmation can be
helpful when the clinical presentation is mild or atypical.
Furthermore, a genetic diagnosis extended to the family
members, could be useful to clarify the risk of recur-
rence and to provide counseling about family planning
and reproductive options.
Management
Management of TRPS is essentially supportive. A multi-
disciplinary care is beneficial, with at least genetic, auxo-
logic, orthopedic counseling.
A regular auxological assessment is important, with
frequent measurement of height and growth velocity. In
patients showing a growth pattern below the normal
range for age and sex, it is indicated to evaluate the
growth hormone (GH) secretion with GH stimulation test,
as several cases of GH deficiency have been described. In
case of proven GH deficiency, GH substitutive therapy
can be considered. Encouraging results have been ob-
tained on growth velocity in a number of cases, however
patients with TRPS may present a remarkable impairment
of bone status with a reduced bone mass and quality,
making them unresponsive to the GH therapy [6, 16–20].
A significant reduction of bone mass and quality, as
well as severe osteoporosis, has been reported in several
patients with TRPS [17, 21]. An evaluation of bone status
with dual X-ray absorptiometry (DXA) could be appropri-
ate. In children, Broadband Ultrasound Attenuation (BUA)
could be used as a valid alternative of DXA in the assess-
ment and monitoring of bone status [22].
Patients can develop secondary joint degeneration, po-
tentially involving any joint, but most commonly hips and
fingers. Osteoarthritis-like changes affecting the large
joints represent the main long-term morbidity associated
with TRPS, leading to pain and decreased mobility, start-
ing from adolescence or early adulthood. MR imaging can
allow an early evaluation of the joints cartilage status,
bringing information about articular consequences and
allowing to rule out other diseases or complications, such
as hip aseptic necrosis. Physiotherapy could improve joint
mobility. Physical exercise should be proposed, while dis-
couraging high-impact or contact sports [14, 23].
Psychological support could be beneficial for individuals
who are uncomfortable with their physical appearance.
Genetic counseling should be offered to all families
with members affected by TRPS. Particularly, young
adults at risk of having child with TRPS could benefit
from discussion of potential risks to offspring and ex-
planation of reproductive options.
Conclusion
Clinical phenotype of TRPS can be subtle and the syn-
drome often remains undiagnosed. A comprehensive
clinical examination and an exhaustive family history
are crucial to reach the correct diagnosis, which is essen-
tial to perform adequate follow-up and timely therapeutic
procedures.
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